Eisenmenger Complex: Clinical Trials

23 trials for Eisenmenger Complex, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 6 unknown, 3 terminated, 2 recruiting. 6 Not applicable, 4 Phase 3, 2 Phase 2, 2 Phase 4, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable6Completed 3, Unknown 2, Terminated 1
Phase 34Completed 2, Terminated 2
Phase 22Completed 1, Not yet recruiting 1
Phase 42Completed 1, Recruiting 1
Early Phase 11Unknown 1

Follow Eisenmenger Complex: new trials by email Literature Review of Eisenmenger Complex trials Research Report on Eisenmenger Complex

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sota-ES - Sotatercept in Patients With Congenital Heart Disease and Eisenmenger´s Syndrome
Sotatercept - Congenital Heart Disease (CHD), Eisenmenger Syndrome
Phase 2Not yet recruitingPhilipps University Marburg402026-09-012026-03-27
A Study of Sotatercept for Patients With Eisenmenger Syndrome or Unrepaired Shunt-Associated Pulmonary Arterial Hypertension Resistant to Vasodilator Therapy
Sotatercept, vasodilator-based PAH therapy - Eisenmenger Syndrome, Pulmonary Arterial Hypertension of Congenital Heart Disease
Phase 4RecruitingKazuya Hosokawa362025-10-072026-01-21
Pentoxifylline as an Adjunct Therapy for Patients With Eisenmenger Syndrome
Pentoxifylline - Eisenmenger Syndrome
Not applicableUnknownUniversity of Sao Paulo General Hospital482022-06-032023-12-15
Real World Difference After Changing Medication From Nonselective to Selective Endothelin Receptor Antagonist in Stable Eisenmenger Syndrome
Eisenmenger Complex
UnknownSamsung Medical Center402021-02-042021-02-01
4DFlow Magnetic Resonance Imaging in Patients With Pulmonary Hypertension Associated With Congenital Heart Disease
4D Flow magnetic resonance imagery, Cardiac catheterization - Congenital Heart Disease, Pulmonary Arterial Hypertension
Not applicableCompletedCentre Chirurgical Marie Lannelongue502018-05-302026-05-01
Six Minutes Walk Test and Shuttle Walk Test in Eisenmenger Syndrome
Eisenmenger Complex, Pulmonary Hypertension
UnknownFederal University of São Paulo602016-04-012016-04-27
Clinical Study to Assess the Long-term Safety, Tolerability, and Efficacy of Macitentan in Subjects With Eisenmenger Syndrome
Macitentan 10 mg tablet, once daily. - Pulmonary Arterial Hypertension
Phase 3TerminatedActelion2172013-09-102019-04-16
Transcatheter Valve Implantation in Patients With Dysfunctional Left and Right Sided Heart Valves
Transcather Valve Implantation - Eisenmenger Syndrome
Not applicableCompletedUniversity of California, Los Angeles902013-08-012019-04-30
Sleep-disordered Breathing in Eisenmenger Syndrome
Polysomnography - Eisenmenger Syndrome, Congenital Heart Disease
CompletedCopenhagen University Hospital, Rigshospitalet202013-06-012015-11-25
Clinical Study to Evaluate the Effects of Macitentan on Exercise Capacity in Subjects With Eisenmenger Syndrome
Macitentan 10 mg, Placebo - Pulmonary Arterial Hypertension
Phase 3CompletedActelion2262013-05-212018-02-23
Eisenmenger Syndrome in the Nordic Countries
Eisenmenger Syndrome
UnknownCopenhagen University Hospital, Rigshospitalet7142012-10-012015-12-24
Exercise Capacity and Quality of Life in Patients With PPH Receiving Short Term Oral L-Citrulline Malate
L-Citrulline Malate - Idiopathic Pulmonary Arterial Hypertension, Eisenmenger Syndrome
Early Phase 1UnknownMasih Daneshvari Hospital252012-08-012013-08-12
Eisenmenger Quality Enhancement Research Initiative
Subjects with diagnosis of Eisenmenger Syndrome - Pulmonary Arterial Hypertension
CompletedActelion1932012-07-012025-02-03
Effects Oxygen Supplementation Determined Better Exercise Capacity in Eisenmenger Syndrome
Oxygen Supplementation - Eisenmenger Complex, Hypertension, Pulmonary
Not applicableCompletedFederal University of São Paulo302012-01-012016-01-25
Respiratory and Physical Therapy in Patients With Associated Pulmonary Arterial Hypertension (APAH) With Congenital Heart Defects
respiratory and exercise therapy - Pulmonary Arterial Hypertension, Eisenmenger Syndrome
Not applicableUnknownHeidelberg University502012-01-012022-07-14
Iloprost for the Treatment of Pulmonary Hypertension in Adults With Congenital Heart Disease
Iloprost - Pulmonary Arterial Hypertension, Congenital Heart Disease
Not applicableTerminatedUniversity of California, Los Angeles52011-06-012015-01-26
Phosphodiesterase-5 Inhibitor in Eisenmenger Syndrome
Tadalafil, placebo - Eisenmenger Syndrome
Phase 2CompletedGovind Ballabh Pant Hospital282008-02-012010-09-14
Therapy of Pulmonary Arterial Hypertension (PAH) - Treatment With Sildenafil in Eisenmenger Patients
Sildenafil, Placebo - Pulmonary Arterial Hypertension (PAH)
Phase 3TerminatedCompetence Network for Congenital Heart Defects242007-12-012012-06-06
The Effects of Inhaled Iloprost on Congenital Heart Disease With Eisenmenger Syndrome
Eisenmenger's Syndrome
CompletedGachon University Gil Medical Center122007-09-012011-01-26
COMPERA / COMPERA-KIDS
Pulmonary Arterial Hypertension (PAH), Pulmonary Hypertension (PH)
RecruitingTechnische Universität Dresden140002007-07-012025-08-24

Showing 20 of 23. Sign in to see all of them.

Narrower conditions

Pulmonary Arterial Hypertension (10)  ·  Heart Defects, Congenital (8)  ·  Hypertension, Pulmonary (5)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Familial Primary Pulmonary Hypertension (1)  ·  Hypertension (1)  ·  Pulmonary Heart Disease (1)  ·  Sleep Apnea Syndromes (1)  ·  Thrombosis (1)

Broader conditions

Cardiovascular Abnormalities (23)  ·  Cardiovascular Diseases (23)  ·  Congenital Abnormalities (23)  ·  Heart Diseases (23)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (22)  ·  Respiratory Tract Diseases (16)  ·  Heart Defects, Congenital (15)  ·  Lung Diseases (15)  ·  Hypertension, Pulmonary (10)  ·  Vascular Diseases (6)  ·  Hypertension (5)  ·  Apnea (1)  ·  Dyssomnias (1)  ·  Embolism and Thrombosis (1)  ·  Nervous System Diseases (1)

Interventions

ACE-011 (2)  ·  Sildenafil Citrate (2)  ·  macitentan (2)  ·  Bosentan (1)  ·  Cardiac Catheterization (1)  ·  Exercise Therapy (1)  ·  Iloprost (1)  ·  Pentoxifylline (1)  ·  Respiratory Rate (1)  ·  Tablets (1)  ·  Tadalafil (1)

Sponsors

Actelion (3)  ·  Copenhagen University Hospital, Rigshospitalet (3)  ·  Competence Network for Congenital Heart Defects (2)  ·  Federal University of São Paulo (2)  ·  University of California, Los Angeles (2)  ·  Centre Chirurgical Marie Lannelongue (1)  ·  Children's Healthcare of Atlanta (1)  ·  Gachon University Gil Medical Center (1)  ·  Govind Ballabh Pant Hospital (1)  ·  Heidelberg University (1)  ·  Kazuya Hosokawa (1)  ·  Masih Daneshvari Hospital (1)  ·  Philipps University Marburg (1)  ·  Samsung Medical Center (1)  ·  Technische Universität Dresden (1)

Countries

Germany (6)  ·  United States (5)  ·  France (3)  ·  Austria (2)  ·  Brazil (2)  ·  Bulgaria (2)  ·  Chile (2)  ·  China (2)  ·  Denmark (2)  ·  Greece (2)  ·  Malaysia (2)  ·  Mexico (2)  ·  Philippines (2)  ·  Poland (2)  ·  Portugal (2)

Top investigators

Ingram Schulze-Neick, MD (2)  ·  Antonio Augusto Barbosa Lopes, MD (1)  ·  Ardeschir H. Ghofrani, MD, PhD (1)  ·  Christian Opitz, MD, PhD (1)  ·  Dario Vizza, MD, PhD (1)  ·  David Pittrow, MD, PhD (1)  ·  Ekkehard Gruenig, MD (1)  ·  Gary Palmer, MD, MBA (1)  ·  Harald Kaemmerer, MD, PhD (1)  ·  Jamil A Aboulhosn, MD (1)  ·  Jamil A Aboulhosn, MD, FACC (1)  ·  Karen Olsson, MD, PhD (1)  ·  Laion Gonzaga, PT (1)

Results publications

PMID 20202971, PMID 21914136, PMID 23164592, PMID 23720182, PMID 24081973, PMID 26630396, PMID 28775047, PMID 29368137, PMID 29450722, PMID 29599117, PMID 30337446, PMID 30586694, PMID 32414075, PMID 33581097, PMID 34737226, PMID 35070795, PMID 35777416, PMID 36333206, PMID 37105586, PMID 37462520, PMID 37802633, PMID 41819579